Recently, the suppression of CSC phenotype in lung cancer induced by alpha-lipoic acid was posited to be driven by the reduction of p-Akt level, which led to the depletion of p-GSK3β, β-catenin, and Oct4 [25]. The gene discussed is AKT1; the disease is lung cancer.